文献速递急性肾损伤

胱抑素C在急性肾损伤患者中比肌酐更早预测肾功能恢复

Cystatin C Predicts Renal Recovery Earlier Than Creatinine Among Patients With Acute Kidney Injury.
PubMed 文献 · Kidney Int Rep · 2017-11-03

这项回顾性研究纳入63例非少尿型急性肾损伤住院患者,分析肌酐与胱抑素C的时间趋势。结果显示68%的患者胱抑素C先于肌酐下降,平均早0.92天(95%CI 0.65-1.18,P<0.001),提示胱抑素C可能更早反映肾功能恢复。

要点

  • 68%的急性肾损伤患者胱抑素C下降早于肌酐。
  • 胱抑素C平均比肌酐早0.92天下降(95%CI 0.65-1.18,P<0.001)。
  • 该发现若经大型前瞻性研究证实,可能有助于缩短住院时间和降低费用。

核心结论

  • 在多数急性肾损伤住院患者中,胱抑素C比肌酐更早下降,提示其可能更早预测肾功能恢复。

研究设计与样本

  • 回顾性研究,纳入2015年5月至2016年5月间收治的63例非少尿型急性肾损伤住院患者,收集人口学、实验室、病因及合并症数据。

主要发现

  • 68%的患者胱抑素C先于肌酐下降:早1天占46%,早2天占16%,早3天占6%。
  • 24%的患者两者同日下降,仅8%的患者胱抑素C下降晚于肌酐。
  • 胱抑素C平均下降时间比肌酐早0.92天(95%CI 0.65-1.18,P<0.001)。

关键数值与推荐

  • 患者平均年龄58.7岁(SD 13.9),男性62%,白人95%。
  • 基线肌酐中位数1.1 mg/dl(范围0.5-3.0),13%为肾移植受者,37%使用糖皮质激素。
  • 合并症包括恶性肿瘤38%、糖尿病33%、心力衰竭19%、甲状腺疾病16%。
  • 急性肾小管坏死占71%,急性肾损伤III期占61%,33%需要透析。

临床怎么用

  • 在急性肾损伤恢复期监测胱抑素C可能比肌酐更早提示肾功能恢复,有助于临床决策。

局限性

  • 回顾性研究,样本量较小(63例),结果需大型前瞻性研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Serum cystatin C increases earlier than creatinine during acute kidney injury. However, whether cystatin C decreases earlier during recovery is unknown. This retrospective study aimed to determine the temporal trend between creatinine and cystatin C in acute kidney injury. METHODS: We identified hospitalized patients with nonoliguric acute kidney injury who had serial creatinine and cystatin C values measured between May 2015 and May 2016. Demographic and laboratory data, causes of acute kidney injury, and relevant comorbidity data were collected through chart review. RESULTS: For the 63 identified patients, mean (SD) age was 58.7 (13.9) years; male sex, 62%; white race/ethnicity, 95%. Baseline median (range) creatinine was 1.1 (0.5-3.0) mg/dl; 13% were kidney transplant recipients and 37% received corticosteroids. Comorbidities included malignancy (38%), diabetes mellitus (33%), heart failure (19%), and thyroid disorder (16%). The cause of kidney injury was acute tubular necrosis in 71%, 61% had acute kidney injury stage III, and 33% required dialysis. Cystatin C began to decrease before creatinine in 68% of patients: 1 day earlier, 46%; 2 days earlier, 16%; and 3 days earlier, 6%. In 24% of cases, both began decreasing on the same day; in only 8%, cystatin C decreased after creatinine. Overall, cystatin C mean (95% confidence interval) decrease was 0.92 (0.65-1.18) days before creatinine (P < 0.001). CONCLUSION: In summary, cystatin C decreases before creatinine in most hospitalized patients with acute kidney injury. If confirmed in large prospective studies, these findings may have important management implications, possibly shortening hospital stay and reducing costs.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Gharaibeh KA, Hamadah AM, El-Zoghby ZM, et al. Cystatin C Predicts Renal Recovery Earlier Than Creatinine Among Patients With Acute Kidney Injury. Kidney Int Rep. 2017. PMID: 29725637. doi:10.1016/j.ekir.2017.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。